C
CareDx D
D
CDNA
17.030
USD
0.56
(3.40%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-43
Market Cap
875,897,842
Title: CareDx
Sector: Healthcare
Industry: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
